MEK Inhibitors
- “Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database”, Ophthalmology (2021)
- “OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS”, Retina (2019)
- “New features in MEK retinopathy”, BMC Ophthalmology (2018)
- “Ocular toxicity due to Trametinib and Dabrafenib”, BMC Ophthalmology (2017)
- “Ocular toxicities of MEK inhibitors and other targeted therapies”, Annals of Oncology (2016)
- “MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity”, Eye (2015)
- “Effect of inhibition of the FGFR–MAPK signaling pathway on the development of ocular toxicities”, Cancer Treatment Reviews (2013)